Athira Pharma Provides 2024 Clinical Pipeline Outlook and Business Update

January 8, 2024

https://www.globenewswire.com/news-release/2024/01/08/2805247/0/en/Athira-Pharma-Provides-2024-Clinical-Pipeline-Outlook-and-Business-Update.html

Completed enrollment in Phase 2/3 LIFT-AD clinical trial of fosgonimeton as a potential treatment for mild-to-moderate Alzheimer’s disease and expects topline data in second half of 2024 

Read more at globenewswire.com

Related news for (ATHA)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.